Technology | April 29, 2015

Volpara Solutions Releases VolparaDensity 3.1

Latest version of breast density analytics software supports tomosynthesis data from all major vendors

VolparaDensity, 3.1, tomosynthesis, mammography

April 29, 2015 — Volpara Solutions announced the release of VolparaDensity version 3.1 at the Society of Breast Imaging’s SBI/ACR Breast Imaging Symposium in Orlando, Florida, April 25-28.

The latest version of VolparaDensity supports digital mammography from all leading vendors and tomosynthesis datasets from Hologic, GE and Siemens tomosynthesis systems. Additionally, VolparaDensity 3.1 supports Hologic sites that use C-View synthetic 2-D images and GE SenoClaire sites that acquire 2-D CC and 3-D MLO images. VolparaDensity uses the same algorithm to process both the acquired tomosynthesis projections and the raw data of a conventional 2-D mammogram. This reduces the challenges of visually determining breast density based on a review of tomosynthesis slices and the new synthetic 2-D images (C-View from Hologic, V-Preview from GE).

“We have been using VolparaDensity for more than two years and find it particularly helpful when assessing breast density in mammograms with a complex dispersion of fibroglandular tissue,” said Kathy Schilling, M.D., of the Christine Lynn Women's Health and Wellness Center at Boca Raton Regional Hospital in Boca Raton, Florida. “We are now very pleased to be using VolparaDensity together with our GE SenoClaire digital breast tomosynthesis acquisitions. Given the demands of reviewing the stacks of tomosynthesis slices and the new synthetic 2-D images, we appreciate the consistent density assessment we get from the Volpara software.”

VolparaDensity 3.1 supports additional features including new configuration flexibility for patient-specific compression pressure calculations and the ability to route patient results by Volpara’s U.S. Food and Drug Administration (FDA)-cleared Volpara Density Grades (VDG), which are analogous to the BI-RADS density categories. Based on a site’s imaging protocols for breast density and risk, users can configure the system to automatically send density results for women with very dense breasts to a specific interpreting radiologist or a breast density specialist at the site for review. This automatic routing may help improve the speed with which sites can identify women who would benefit from additional screening, particularly sites that perform same-day adjunctive screening.    

VolparaDensity is in use at breast imaging centers worldwide to help radiologists objectively assess density from both digital mammography and tomosynthesis images and to determine which women would benefit from additional screening. Highly correlated to breast magnetic resonance (MR) assessments, VolparaDensity automatically generates an objective measurement of volumetric breast density correlated to the American College of Radiology (ACR) breast density categories.

For more information: www.volparasolutions.com

Related Content

GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium

GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium in Hollywood, Florida. Photo by Greg Freiherr

Feature | Breast Imaging | April 23, 2019 | By Greg Freiherr
Signs of what the future may look like in women’s health dotted the exhibit floor of the...
In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr
Commercial efforts to develop...
Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr
When planning a screening program to detect the early signs of breast cancer, age is a major consideration.
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
compressed breast during mammography.
360 Photos | 360 View Photos | April 16, 2019
A 360 view of a simulated breast compression for a...
A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images

A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images. The algorithm, described at the SBI/ACR Breast Imaging Symposium, used “Deep Learning,“ a form of machine learning, which is a type of artificial intelligence. Graphic courtesy of Sarah Eskreis-Winkler, M.D.

Feature | Artificial Intelligence | April 12, 2019 | By Greg Freiherr
The use of smart algorithms has the potential to make healthcare more efficient.
This image depicts ABUS images with QVCAD results

This image depicts ABUS images with QVCAD results.

Feature | Breast Imaging | April 12, 2019
Imaging Technology News spoke with Bob Foley, vice president of sales and marketing of QView Medical, Inc.,